NCT03153189 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Anjana RM, Pradeepa R, Das AK, Deepa M, Bhansali A, Joshi SR, Joshi PP, Dhandhania VK, Rao PV, Sudha V, Subashini R, Unnikrishnan R, Madhu SV, Kaur T, Mohan V, Shukla DK; ICMR– INDIAB Collaborative Study Group
. Physical activity and inactivity patterns i
Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F
Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002 Sep;53(3):737-40.
Rimer J, Dwan K, Lawlor DA, Greig CA, McMurdo M, Morley W, Mead GE
Exercise for depression. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004366. doi: 10.1002/14651858.CD004366.pub5. Review. Update in: Cochrane Database Syst Rev. 2013;(9):CD004366.

Correlates of Physical Activity With Anthropometric Traits, Mental Health and Quality of Life in College Women of Manipal University

Clinical trial NCT03153189 - References